# Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.

> **NCT02684812** · PHASE2,PHASE3 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 955 (actual)

## Conditions studied

- Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT02684812
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-16
- **Primary completion:** 2019-07-29
- **Final completion:** 2020-11-01
- **Target enrollment:** 955 (ACTUAL)
- **Last updated:** 2020-11-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02684812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02684812, "Ultra-early Tranexamic Acid After Subarachnoid Hemorrhage.". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02684812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*